VIZAMYL™
VIZAMYL™ is a radiopharmaceutical medicinal product indicated for Positron Emission Tomography (PET) imaging of β-amyloid neuritic plaque density in the brains of adult patients who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive impairment.

Negative Scan
Positive Scan
VIZAMYL™ is a TradeMark of GE Healthcare
VIZAMYL™ is a TradeMark of GE Healthcare.